BTOG 2019 | Immunotoxicity in advanced lung cancer: how does this influence future practice?

Tom Newsom-Davis, BSc, MBBS, PhD, FRCP, of the Chelsea and Westminster Hospital NHS Foundation Trust, London, UK, discusses what lessons can be learnt from immunotoxicity in advanced lung cancer, and how this could influence future practice. This interview took place at the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland.